Education
About Us
Working with TipRanks
Follow Us
MariMed Inc (TSE:MRMD)
:MRMD
MRMD Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.07 - C$0.60
Previous CloseN/A
Volume0.00
Average Volume (3M)73.69K
Market Cap
$41.88M
Enterprise ValueC$162.38M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.94
Next Earnings
May 07, 2025EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding382,173,980
10 Day Avg. Volume18,912
30 Day Avg. Volume73,692
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.24
Price to Cash Flow (P/CF)-22.60
P/FCF Ratio2.30
Enterprise Value/Market Cap3.88
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.58
Enterprise Value/Ebitda11.38
Forecast
1Y Price Target
C$0.35Price Target Upside216.60% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
MariMed News
PremiumCompany Announcements
MariMed’s Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
MariMed Reports Record Revenue Amid Strategic Growth
---
Options Prices
Currently, No data available
---
Ownership Overview
10.17% Insiders
―
Mutual Funds
0.19% Other Institutional Investors
89.64% Public Companies and
Individual Investors
MRMD FAQ
What was MariMed Inc’s price range in the past 12 months?
MariMed Inc lowest stock price was C$0.07 and its highest was C$0.60 in the past 12 months.
What is MariMed Inc’s market cap?
MariMed Inc’s market cap is $41.88M.
When is MariMed Inc’s upcoming earnings report date?
MariMed Inc’s upcoming earnings report date is May 07, 2025 which is in 24 days.
How were MariMed Inc’s earnings last quarter?
MariMed Inc released its earnings results on Mar 05, 2025. The company reported -C$0.028 earnings per share for the quarter, missing the consensus estimate of -C$0.014 by -C$0.014.
Is MariMed Inc overvalued?
According to Wall Street analysts MariMed Inc’s price is currently Undervalued.
Does MariMed Inc pay dividends?
MariMed Inc does not currently pay dividends.
What is MariMed Inc’s EPS estimate?
MariMed Inc’s EPS estimate is -0.01.
How many shares outstanding does MariMed Inc have?
MariMed Inc has 382,173,980 shares outstanding.
What happened to MariMed Inc’s price movement after its last earnings report?
MariMed Inc reported an EPS of -C$0.028 in its last earnings report, missing expectations of -C$0.014. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of MariMed Inc?
Currently, no hedge funds are holding shares in TSE:MRMD
---
MariMed Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$0.35 (216.60% Upside)
C$0.35 (216.60% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 4.2%
Last 30 Days ▼ 4.2%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-70.00%
12-Months-Change
Fundamentals
Return on Equity
-18.27%
Trailing 12-Months
Asset Growth
5.54%
Trailing 12-Months
Company Description
MariMed Inc
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
---
MRMD Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a mixed performance for MariMed, with strong wholesale revenue growth and brand performance contributing positively, while challenges in the retail segment and decreased profit margins presented significant hurdles. The company has a strategic focus on expansion and operational efficiencies to drive future growth.Read More>---
MRMD Stock 12 Month Forecast
Average Price Target
C$0.35
▲(216.60% Upside)
Technical Analysis
General Cannabis
―
Curaleaf Holdings
―
Green Thumb Industries
―
Trulieve Cannabis
―
Cresco Labs
―
Best Analysts Covering MRMD
1 Year
1 Year Success Rate
0/13 ratings generated profit
1 Year Average Return
-40.52%
reiterated a buy rating 11 months ago
Copying Andrew Semple's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -40.52% per trade.
---